Lv1
40 积分 2023-10-18 加入
Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents
6天前
已完结
Atopic dermatitis Yardstick: a new era of topical and systemic treatments
7天前
已关闭
Drug survival rate and safety of dupilumab in the treatment of atopic dermatitis in elderly patients: a retrospective cohort analysis
29天前
已关闭
Stapokibart for the Treatment of Refractory Palmoplantar Pustulosis
2个月前
已完结
A revised nomenclature for allergy: An EAACI position statement from the EAACI nomenclature task force
3个月前
已完结
American Academy of Dermatology Guidelines: Awareness of comorbidities associated with atopic dermatitis in adults
3个月前
已完结
Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis
3个月前
已完结
Efficacy and Safety of Extending Dosing Interval of Stapokibart in Patients with Atopic Dermatitis
3个月前
已完结
Advancements in pharmacological interventions for atopic dermatitis current strategies and future directions
3个月前
已完结
Atopic dermatitis relapse after treatment discontinuation and predictive factors for relapse: JAK1 inhibitors versus dupilumab
3个月前
已完结
皖公网安备34019202002308
